Journal of Physiology and Pathophysiology
Subscribe to JPAP
Full Name*
Email Address*

Article Number - 974E7B515872

Vol.4(4), pp. 46-57 , September 2013
DOI: 10.5897/JPAP2013.0001
ISSN: 2141-260X


The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus

Ozougwu, J. C.1*, Obimba, K. C.2, Belonwu, C. D.3, and Unakalamba, C. B.4

1Physiology and Biomedical Research Unit, Department of Biological Sciences, College of Basic and Applied Sciences, Rhema University Aba, Abia StateNigeria.

2Department of Biochemistry, School of Science, Federal University of Technology Owerri, Imo State. Nigeria.

3Department of Biochemistry, Faculty of Chemical Sciences, University of Portharcourt, Rivers State. Nigeria.

4Department of Zoology and Environmental Biology, University of Nigeria, Nsukka, Enugu state, Nigeria.


 Accepted: 17 June 2013  Published: 30 September 2013

Copyright © 2013 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0

The aim of this paper is to review the information on type 1 and type 2 diabetes with emphasis on its etiology, pathogenesis and pathophysiology via literature review. Diabetes is a group of metabolic disorders characterized by a chronic hyperglycemic condition resulting from defects in insulin secretion, insulin action or both. Type 1 diabetes is the result of an autoimmune reaction to proteins of the islets cells of the pancreas while type 2 diabetes is caused by a combination of genetic factors related to impaired insulin secretion, insulin resistance and environmental factors such as obesity, overeating, lack of exercise and stress, as well as aging. The pathogenesis of selective β-cell destruction within the islet in type 1 diabetes mellitus is difficult to follow due to marked heterogeneity of the pancreatic lesions. At the onset of overt hyperglycemia, a mixture of pseudoatrophic islets with cells producing glycogen, somatostatin and pancreatic polypeptide, normal islets and islets containing both β-cells and infiltrating lymphocytes and monocytes may be seen. The autoimmune destruction of pancreatic β cells leads to a deficiency of insulin secretion that leads to the metabolic derangements associated with type 1 diabetes. The main pathophysiological features of type 2 diabetes are impaired insulin secretion and increased insulin resistance. The impairment of pancreatic β cell function notably shows progression overtime in type 2 diabetes although aging, obesity, insufficient energy consumption, alcohol drinking, smoking, etc are independent risk factors of pathogenesis of type 2 diabetes mellitus.   


Key words: Diabetes Mellitus, Pathophysiology, Pathogenesis, Etiology.

Akinmokun A, Harris P, Home PD, Alberti KG (1992). Is diabetes always diabetes? Diabetes Res. Clin. Pract. 18:131-136.
Al Homsi MF, Lukic ML (1992). An Update on the pathogenesis of Diabetes Mellitus, Department of Pathology and Medical Microbiology (Immunology Unit)Faculty of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
American Diabetes Association (2001). Diabetes 2001 Vital statistics. Alexandra, VA: ADA.
Bennett N, Dodd T, Flatley J, Freeth S, Boiling K (1995). Health survey for England 1993, London; HMSO.
Blood A, Hayes TM, Gamble DR (1975). Register of newly diagnosed diabetic children. BMJ. 3:580-583.
Bjorntorp P (1992). Abdominal fat distribution and disease: an overview of epidemiological data. Annals Med. 24(1):15-18.
Bonadonna RC, Saccomani MP, Seely L, et al. (1993). Glucose transport in human skeletal muscle: the in vivo response to insulin. Diabetes. 42:191-198.
Campbell IT, Kay TWH, Oxbrow L, Harrison TC (1991). Essential role for Interferon Gama and interleukin 6 in autoimmune, insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:739-742.
PMid:1899431 PMCid:PMC296368
Comi RJ, Grunberger G, Gorden P (1987). Relationship of insulin binding and Insulin-stimulated tyrosine kinase activity is altered in type II diabetes. J. Clin. Invest. 79:453-62.
PMid:3543053 PMCid:PMC424100
Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB (2009). Diabetes in Asia; epidemiology, risk factors, and pathophysiology. JAMA, 301:2129-2140.
Colagiuri S (2010). Diabesity; Therapeutic Options. Diabetes Obes. Metab. 12:463-473.
Cook JT, Hattersley AT, Levy JC, Patel P, Wainscoat JS, Hockaday TD, Turner RC (1993). Distribution of Type II diabetes in nuclear families. Diabetes. 42:106-12.
Defronzo RA, Ferrannini E (1988). Lily Lecture 1987. The Triumvirate: Beta Cell, Muscle, Liver. A Collusion Responsible for NIDDM. Diabetes. 37:667-687.
Enoki S, Mitsukawa T, Takemura J, Nakazato M, Aburaya J, Toshimori H, Matsukara S (1992). Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 15(l):97-102.
EURODIAB ACE Study Group (2000). Variation and trends in incidence of childhood diabetes in Europe, Lancet. 335:873-876.
Evephart JE, Pettit DJ, Bennett PH, Knowler WC (1992). Duration of obesity increases the incidence of NIDDM. Diabetes. 41:235-240.
Felber JP (1992). From obesity to diabetes: pathophysiological considerations. Int. J. Obes. 1992; 16:937-952.
Fowell D, Mcknight AI, Powrie F, Dyke R, Mason D (1991). Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123:37-64.
Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P,Permutt MA,Beckmann JS, Bell GI, Cohen D (1993). Familial hyperglycemia due to mutations in glucokinase definition of a subtype of diabetes mellitus. N Engl J Med. 328(10):697-702.
Gabbay K H (1980). The Insulinopathies. N. Engl. J. Med. 302:165-7.
González EL, Johansson S, Wallander MA, Rodríguez LA (2009). Trends in the prevalence and incidence of diabetes in the UK: 1996 – 2005. J. Epidemiol. Community Health. 63: 332-336.
Gill RG, Haskins K (1993). Molecular mechanisms underlying diabetes and other autoimmune diseases. Immunol. Today. M:49-51.
Guyton AC, Hall JE (2006). Textbook of Medical physiology. 11th Edition. Elsevier Inc, New Delhi.
Haffner SM, Mitchell BD, Stern MP, Hazuda HP, Patterson JK (1992). Public health significance of upper body adiposity for non-insulin dependent diabetes in Mexican Americans. Int. J. Obes. 16(3):177-184.
Hattersley AT, Turner RC, Permutt MA, Patel P, Tanizawa Y, Chiu KC, O'Rahilly S, Watkins P, Wainscoat JS (1992). Linkage of type 2 diabetes to the glucokinase gene. Lancet. 339:1307-1310.
Holt G. I. (2004). Diagnosis, epidemiology and pathogenesis of diabetes mellitus an update for Psychiatrists. Br. J. Psychiatry. 184:s55- s63.
Joffe BI, Panz VR, Wing JR, Raal FJ, Seftel HC (1992). Pathogenesis of noninsulin- dependent diabetes mellitus in the black population of southern Africa. Lancet. 340(8817):460-462.
Kahu RC, White MF (1988). The insulin receptor and the molecular mechanism of insulin action. J. Clin. Invest. 82:1151.
PMid:3049671 PMCid:PMC442664
Kaku K (2010). Pathophysiology of type 2 diabetes and its treatment policy. JMAJ, 53(1):41-46.
Karvonen M, Pitkaniemi J, Tuomilehto J (1999). The onset age of type 1 diabetes in Finnish children has become younger. The Finnish childhood diabetes Registry Group. Diabetes care. 22:1066-1070.
Knowler WC, Nelson RG, Saad MF, Bennett PH, Pettitt DJ (1993). Determinants of diabetes mellitus in the Pima Indians. Diabetes Care. 16:216-227.
Knowler WC, Pettitt DJ, Sadd M, Bennett PH (1990). Diabetes mellitus in the Pina Indians: incidence, risk factors and pathogenesis. Diabetes/Metab.Rev 6:1-27.
Kolb, H, Kolb-bachofen (1992). Nitric oxide a pathogenetic factor in autoimmunity. Immunol. Today, 13:157-159.
Kolb-bachofen V, Epstein SQ, Kiesel U, Kolb H (1988). Low dose streptozocin induced diabetes in mice. Electron microscopy reveals single-cells insulitis before diabetes onset. Diabetes. 37:21-27.
Kroncke KD, Kolb-bachofen V, Berschick B, Burkart V, Kolb H (1991). Activated macrophages kill pancreatic syngeneic islet via arginine-dependent nitric oxide generation. Biochem. Biophys. Res. Commun.175:752-758.
Levy JR, Hug V (1993). Nuclear protein-binding analysis of a GC-rich insulin-receptor promotor regulator region. Diabetes, 42: 66-73.
Lukic ML, Al-sharif R, Mostarica M, Bahr G, Behbehani K (1991). Immunological basis of the strain differences in susceptibility to low-dose streptozotocininduced diabetes in rats. In: Lymphatic Tissues and In vivo Immune Responses . Eds. Imhof. et al.; New York. Marcel Dekker Inc. pp 643-647.
Lukic ML, Stosic-Grujicic S, Ostojic N, Chan WL, Liew FY (1991). Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem. Biophys. Res. Commun. 178:913-920.
Mandrup-poulsen T, Spinas GA, Prowse SJ, Hansen BS, Jorgensen DW, Bendtzen K, Nielsen JH, Nerup J (1987). Islet cytotoxicity of interleukin-l. Influence of culture conditions and islet donor characteristics. Diabetes, 1987;36:641-647.
McVeigh GE, Brennan GM, Johnston GD, McDermott BJ, McGrath LT, Henry WR, Andrews JW, Hayes JR (1993). Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 36:33.-38.
Molina JM, Cooper GIS, Leighton B, Olefsky JM (1990). Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes. 39:260-5.
Mueckler M (1990). Family of glucose-transporter genes: implications for glucose homeostasis and diabetes. Diabetes. 39:6-11.
National Diabetes Data Group (1979). Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 28:1039-1057.
Neil HA, Gatling W, Mather HM, Thompson AV, Thorogood M, Fowler GH, Hill RD, Mann JI (1987). The Oxford community Diabetes study; evidence for an increase in the prevalence of known diabetes in Great Britain. Diabetic Med. 4:539-543.
Njolstad PR, Sagen JV, Bjorkhaug L, Odili S, Shehadeh N, Bakry D, Sarici, S. U., Alpay, F., Molnes, J., Molven, A., Sovik, O. and Matschinsky, F. M. (2003). Permanent neonatal diabetes caused by glucokinase deficiency: inborn error of the glucose-insulin signaling pathway. Diabetes. 52(11):2854-60.
Wilson PW, Mcghee DL, Kannel WB (1981). Obesity, very low density lipoproteins and glucose intolerance over fourteen years: the Framingham study. Am. J. Epidemiol. 114:697-704.
Oelbaum RS (1992). Analysis of three glucose transporter genes in a Caucasian population:no associations with non insulin-dependent diabetes and obesity. Clin. Genet. 42:260- 266.
Ohagi S, Ekawa K, Sanke K, Nishi M, Nanjo K (1992). Restriction fragment length polymorphisms near the islet amyloid polypeptide gene in Japanese subjects. Diabetes Res. Clin. Pract.18:71-74
Raju SM, Raju B (2010). Illustrated medical biochemistry. 2nd Edition. Jaypee Brothers Medical Publishers ltd, New Delhi, India. 645pp
Richens ER, Abdella N, Jayyab AK., Alsaffar M, Behbehani K (1988); Type 2 Diabetes in Arab patients in Kuwait. Diabetic Med. 5:231-234.
Type 2 Diabetes in Arab patients in Kuwait. Diabetic Med. 5:231-234.
Rowley WR, Bezold C. (2012)."Creating public awareness: state 2025 diabetes forecasts." Population Health Management. 15.
Shaw JE, Sicree RA, Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87:4-14.
Steiner DF, Ohagi S, Nagamatsu S, Bell GI, Nishi M (1991). Is Islet Amyloid Polypeptide a Significant Factor in Pathogenesis or Pathphysiology of Diabetes. Diabetes. 40(3):305-309.
Sten-Linder M, Wedell A, Iselius L, Efendic S, Luft R, Luthman H (1993). DNA polymorphisms in the human tyrosine hydroxylase/insulin/insulin-like growth factor II chromosomal region in relation to glucose and insulin responses. Diabetologia. 36:25-32.
Tattershall RB (1991). Maturity-onset diabetes of the young (MODY) in Pickup and Williams. Textbook of Diabetes. 1:246.
Ulaeto D, Lacy PE, Kipnis DM, Kanagawa O, Unanue ER (1992). A T-cell dormant state in the autoimmune process of non-obese diabetic mice treated with complete Freund's adjuvant. Proc. Natl. Acad. Sci. USA, 89:3927-3931.
PMid:1570315 PMCid:PMC525604
Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P (1992). Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature. 356:721-722.
Vuorinen-Markkola H, Koivisto VA, Ykijarvinen H (1992). Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type 1 diabetic patients. Diabetes. 41:571-580.
Westermark P (1973). Fine Structure of Islets of Langerhans in Insular Amyloidosis. Vichows Arch. Path. Anat. 359:1-18.
Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J, Makino S, Harada M (1992). Analysis of the roles of CD4+ T cells in autoimmune diabetes of NOD mice using transfer to NOD male mice. Eur. J. Immunol. 22:2387-2393.
Zavala AV, Fabiano de Bruno LE, Cardoso AI, Mota AH, Capucchio M, Poskus E, Fainboim L, Basabe JC (1992). Cellular and humoural autoimmunity markers in Type 2 (non-insulin-dependent.) diabetic patients with secondary drug failure. Diabetologia. 35:1159-1164.


APA (2013). The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal of Physiology and Pathophysiology, 4(4), 46-57.
Chicago Ozougwu, J. C., Obimba, K. C., Belonwu, C. D., and Unakalamba, C. B.. "The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus." Journal of Physiology and Pathophysiology 4, no. 4 (2013): 46-57.
MLA Ozougwu, et al. "The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus." Journal of Physiology and Pathophysiology 4.4 (2013): 46-57.
DOI 10.5897/JPAP2013.0001

Subscription Form